Jane Street’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,420
| Closed | -$42.7K | – | 6065 |
|
|
2025
Q1 | $42.7K | Sell |
11,420
-38,467
| -77% | -$144K | ﹤0.01% | 5322 |
|
|
2024
Q4 | $506K | Buy |
49,887
+36,237
| +265% | +$368K | ﹤0.01% | 3948 |
|
|
2024
Q3 | $170K | Sell |
13,650
-89,682
| -87% | -$1.12M | ﹤0.01% | 5306 |
|
|
2024
Q2 | $1.34M | Buy |
103,332
+91,889
| +803% | +$1.2M | ﹤0.01% | 3256 |
|
|
2024
Q1 | $259K | Sell |
11,443
-6,921
| -38% | -$157K | ﹤0.01% | 4770 |
|
|
2023
Q4 | $238K | Buy |
+18,364
| New | +$238K | ﹤0.01% | 4861 |
|
|
2023
Q3 | – | Sell |
-44,158
| Closed | -$1.19M | – | 5449 |
|
|
2023
Q2 | $1.19M | Buy |
+44,158
| New | +$1.19M | ﹤0.01% | 2897 |
|
|
2023
Q1 | – | Sell |
-6,489
| Closed | -$331K | – | 5917 |
|
|
2022
Q4 | $331K | Buy |
6,489
+5,504
| +559% | +$281K | ﹤0.01% | 3855 |
|
|
2022
Q3 | $81K | Sell |
985
-12,921
| -93% | -$1.06M | ﹤0.01% | 4967 |
|
|
2022
Q2 | $941K | Sell |
13,906
-13,884
| -50% | -$940K | ﹤0.01% | 2837 |
|
|
2022
Q1 | $3.07M | Buy |
27,790
+13,980
| +101% | +$1.55M | ﹤0.01% | 1675 |
|
|
2021
Q4 | $1.33M | Buy |
13,810
+11,921
| +631% | +$1.15M | ﹤0.01% | 2400 |
|
|
2021
Q3 | $165K | Buy |
1,889
+93
| +5% | +$8.12K | ﹤0.01% | 4492 |
|
|
2021
Q2 | $278K | Sell |
1,796
-3,092
| -63% | -$479K | ﹤0.01% | 4072 |
|
|
2021
Q1 | $771K | Buy |
4,888
+157
| +3% | +$24.8K | ﹤0.01% | 2833 |
|
|
2020
Q4 | $1.1M | Sell |
4,731
-764
| -14% | -$177K | ﹤0.01% | 2008 |
|
|
2020
Q3 | $1.2M | Sell |
5,495
-1,673
| -23% | -$366K | ﹤0.01% | 1615 |
|
|
2020
Q2 | $2.04M | Buy |
+7,168
| New | +$2.04M | ﹤0.01% | 1332 |
|
|
2020
Q1 | – | Sell |
-996
| Closed | -$286K | – | 3723 |
|
|
2019
Q4 | $286K | Sell |
996
-432
| -30% | -$124K | ﹤0.01% | 2714 |
|
|
2019
Q3 | $206K | Buy |
+1,428
| New | +$206K | ﹤0.01% | 3035 |
|
|
2014
Q3 | – | Sell |
-942
| Closed | -$658K | – | 2479 |
|
|
2014
Q2 | $658K | Buy |
+942
| New | +$658K | 0.01% | 987 |
|